株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

前臨床CROの世界市場:サービス、エンドユーザー、地域別 - 2027年までの予測・分析

Pre-Clinical CROs Market to 2027 - Global Analysis and Forecasts By Service ; End User, and Geography

発行 The Insight Partners 商品コード 913818
出版日 ページ情報 英文 139 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.95円で換算しております。
前臨床CROの世界市場:サービス、エンドユーザー、地域別 - 2027年までの予測・分析 Pre-Clinical CROs Market to 2027 - Global Analysis and Forecasts By Service ; End User, and Geography
出版日: 2019年09月30日 ページ情報: 英文 139 Pages
概要

世界の前臨床CRO市場は、2018年に42億8,242万米ドルとなりました。同市場は、2019年から2027年の間に8.1%のCAGRで成長する見通しで、2027年には84億1,290万米ドルに達すると予測されています。

当レポートは世界の前臨床CRO市場について調査しており、市場機会や動向、成長および阻害要因、サービス・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 イントロダクション

  • 調査範囲
  • The Insight Partners調査レポートのガイダンス
  • 市場セグメント

第2章 要点

第3章 調査方法

  • 調査範囲
  • 二次調査
  • 一次調査

第4章 市況

  • 概要
  • PEST分析
  • 専門家の意見

第5章 主要産業力学

  • 主な市場成長要因
  • 主な市場阻害要因
  • 主な市場機会
  • 今後の動向
  • 影響分析

第6章 世界の市場分析

  • 市場収益予測/分析
  • 市場予測/分析:地域別
  • 主要企業の実績

第7章 市場分析:サービス別

  • 概要
  • 市場シェア(2018年・2027年)
  • 生物分析・DMPK研究

第8章 市場分析:エンドユーザー別

  • 概要
  • 市場シェア(2018年・2027年)
  • バイオ医薬品企業
  • 政府機関・学術機関
  • 医療機器企業

第9章 市場分析:地域別

  • 北米
  • 欧州
  • アジア太平洋地域
  • 中東・アフリカ
  • 中南米

第10章 競合情勢

  • 概要
  • 市場の成長戦略(2016年~2019年)
  • 有機的成長戦略
  • 無機的成長戦略

第11章 前臨床CRO市場の主要企業プロファイル

  • MD Biosciences, Inc.
  • WuXi AppTec
  • Pharmaceutical Product Development, LLC.
  • Covance Inc.
  • Charles River
  • PRA Health Sciences, Inc.
  • Medpace
  • Parexel International Corporation
  • ICON Plc
  • Eurofins Scientific

第12章 付録

  • The Insight Partnersについて
  • 用語集
図表

LIST OF TABLES

  • Table 1. R&D Investments by Major Pharmaceutical Companies
  • Table 2. R&D Investments by PhRMA Member Companies,2016
  • Table 3. Number of Studies Registered for Clinical Trials
  • Table 4. North America Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
  • Table 5. North America Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 6. US: R&D Investments by Pharmaceutical Companies, (2015-2016)
  • Table 7. US Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
  • Table 8. US Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 9. Canada Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
  • Table 10. Canada Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 11. Mexico Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
  • Table 12. Mexico Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 13. Europe Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
  • Table 14. Europe Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 15. UK Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
  • Table 16. UK Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 17. Germany Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
  • Table 18. Germany Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 19. France Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
  • Table 20. France Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 21. Italy Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
  • Table 22. Italy Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 23. Spain Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
  • Table 24. Spain Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 25. Asia Pacific Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
  • Table 26. Asia Pacific Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 27. China: Major global pharmaceutical companies by R&D investments, 2013
  • Table 28. China Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
  • Table 29. China Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 30. India: R&D spending of Pharmaceutical companies (2010 & 2017)
  • Table 31. India Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
  • Table 32. India Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 33. Japan Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
  • Table 34. Japan Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 35. Australia Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
  • Table 36. Australia Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 37. South Korea Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
  • Table 38. South Korea Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 39. Middle East & Africa Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
  • Table 40. Middle East & Africa Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 41. South Africa Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
  • Table 42. South Africa Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 43. Saudi Arabia Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
  • Table 44. Saudi Arabia Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 45. UAE Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
  • Table 46. UAE Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 47. South and Central America Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
  • Table 48. South and Central America Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 49. Argentina Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
  • Table 50. Argentina Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 51. Brazil Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
  • Table 52. Brazil Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 53. Recent Expansion & Other Activities By Players In The Pre-Clinical CROs Market
  • Table 54. Recent Product Launches in the Pre-Clinical CROs Market
  • Table 55. Recent Acquisitions By Players In The Pre-Clinical CROs Market
  • Table 56. Recent Agreements & Collaborations By Players In The Pre-Clinical CROs Market
  • Table 57. Recent Partnerships By Players In The Pre-clinical CROs Market
  • Table 58. Glossary of Terms, Pre-Clinical CROs Market

LIST OF FIGURES

  • Figure 1. Pre-Clinical CROs Market Segmentation
  • Figure 2. Pre-Clinical CROs Market Segmentation, by Region
  • Figure 3. Global Pre-Clinical CROs Market Overview
  • Figure 4. Imaging Segment Held Largest Share Of The Service Segment In Pre-Clinical CROs Market
  • Figure 5. Asia Pacific Region Is Expected To Show Remarkable Growth During The Forecast Period
  • Figure 6. Global Pre-Clinical CROs Market, By Geography (US$ Mn)
  • Figure 7. Global Pre-Clinical CROs Market- Leading Country Markets (US$ Mn)
  • Figure 8. Global Pre-Clinical CROs Market, Industry Landscape
  • Figure 9. North America : PEST Analysis
  • Figure 10. Europe: PEST Analysis
  • Figure 11. Asia - Pacific: PEST Analysis
  • Figure 12. Middle East & Africa: PEST Analysis
  • Figure 13. South & Central America: PEST Analysis
  • Figure 14. Number of Approvals for NDA & BLA (2005 to 2016)
  • Figure 15. Impact Analysis of Driver and Restraints Pertaining to Pre-Clinical CROs Market
  • Figure 16. Global Pre-Clinical CROs Market - Revenue Forecasts and Analysis - 2018- 2027
  • Figure 17. Global Pre-Clinical CROs Market - by Geography Forecasts and Analysis - 2018- 2027
  • Figure 18. Prominent Players in the Pre-Clinical CROs Market
  • Figure 19. Global Pre-Clinical CROs Market, by Service 2018 & 2027 (%)
  • Figure 20. Global Bio-Analysis and DMPK Studies Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 21. Global Toxicology Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 22. Global Other Services Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 23. Global Pre-Clinical CROs Market, by End User 2018 & 2027 (%)
  • Figure 24. Global Biopharmaceutical Companies Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 25. Global Government & Academic Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 26. Global Medical Device Companies Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 27. North America Pre-Clinical CROs Market Revenue, by Country, 2018 (US$ Mn)
  • Figure 28. North America Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 29. North America Pre-Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)
  • Figure 30. US Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 31. Canada Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 32. Mexico Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 33. Europe Pre-Clinical CROs Market Revenue, by Country, 2018 (US$ Mn)
  • Figure 34. Europe Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 35. Europe Pre-Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)
  • Figure 36. UK Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 37. Germany Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 38. France Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 39. Italy Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 40. Spain Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 41. Asia Pacific Pre-Clinical CROs Market Revenue, by Country, 2018 (US$ Mn)
  • Figure 42. Asia Pacific Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 43. Asia Pacific Pre-Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)
  • Figure 44. China Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 45. India Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 46. Japan Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 47. Australia Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 48. South Korea Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 49. Middle East & Africa Pre-Clinical CROs Market Revenue, by Country, 2018 (US$ Mn)
  • Figure 50. Middle East & Africa Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 51. Middle East & Africa Pre-Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)
  • Figure 52. South Africa Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 53. Saudi Arabia Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 54. UAE Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 55. South and Central America Pre-Clinical CROs Market Revenue, by Country, 2018 (US$ Mn)
  • Figure 56. South and Central America Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 57. South and Central America Pre-Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)
  • Figure 58. Argentina Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 59. Brazil Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 60. Growth Strategies in the Pre-Clinical CROs Market, 2016-2019
  • Figure 61. Organic Growth Strategies in the Pre-Clinical CROs Market, 2016-2019 (%)
  • Figure 62. Inorganic Developments in the Pre-Clinical CROs Market, 2016-2019(%)
目次
Product Code: TIPRE00003316

The global pre-clinical CROs market is expected to reach US$ 8,412.9 Mn in 2027 from US$ 4,282.42 Mn in 2018. The pre-clinical CROs market is estimated to grow with a CAGR of 8.1% from 2019-2027.

The market is driven by factors such as, increasing R&D expenditures and higher cost of drug development process in developed countries. However, dearth of skilled professionals may limit the growth of the market to a certain extent.

Increasing R&D expenditures made by the companies has been driving the growth of the pre-clinical CROs market. Research & development (R&D) is a significant and essential part of a company's business. Pharmaceutical and biotech companies majorly focus on research and development (R&D) to come up with new molecules for various therapeutic applications with the most significant medical and commercial potential. The companies invest majorly on the R&Ds intending to deliver high quality and innovative products to the market. R&D investments made by biopharmaceutical companies has increased over the years. As per a report published by Pharmaceutical Research and Manufacturers of America (PhRMA), the R&D expenditure of the biopharmaceutical companies has increased from US$49.6 billion in 2012 to US$ 58.8 billion in 2015. R&D not only leads to huge investment but also leads to the involvement of several years. The process from early detection or design to development to regulatory approval can take more than 10 to 15 years. Throughout the development phase of a drug substance, various testing services are required to check the quality and efficacy of the product. Hence, the pharmaceutical and biotech companies prefer to outsource the services to the contract research organizations (CROs) to save the cost and time, which is expected to drive the growth of the market.

Global pre-clinical CROs were segmented by service and end user. Based on the service segment, the market is categorized as, bio-analysis & DMPK studies, toxicology, and other services. On the basis of end user, the market is classified as, biopharmaceutical companies, government & academic institutes, and medical device companies.

Some of the major primary and secondary sources included in the report include, World Health Organization, Association of Clinical Research Organization, European Federation of Pharmaceutical Industries and Associations, European CRO Federation, and Pharmaceutical Research and Manufacturers of America, among others.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the pre-clinical CROs market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global pre-clinical CROs market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Pre-Clinical CROs Market - By Service
    • 1.3.2 Global Pre-Clinical CROs Market - By End User
    • 1.3.3 Global Pre-Clinical CROs Market - By Geography

2. Global Pre-Clinical CROs Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global Pre-Clinical CROs Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 Middle East & Africa PEST Analysis
    • 4.2.5 South & Central America PEST Analysis
  • 4.3 Expert Opinions

5. Global Pre-Clinical CROs Market - Key Industry Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Increasing R&D Expenditures
    • 5.1.2 Higher Cost of Drug Development Process in Developed Countries
  • 5.2 Key Market Restraint
    • 5.2.1 Dearth of Skilled Professionals
  • 5.3 Key Market Opportunities
    • 5.3.1 Rising Biosimilars and Biologics Market
  • 5.4 Future Trends
    • 5.4.1 Increasing Number of Clinical Trials
  • 5.5 Impact Analysis

6. Pre-Clinical CROs Market - Global Analysis

  • 6.1 Global Pre-Clinical CROs Market Revenue Forecasts And Analysis
  • 6.2 Global Pre-Clinical CROs Market, By Geography - Forecasts And Analysis
  • 6.3 Performance of Key Players

7. Global Pre-Clinical CROs Market Analysis- by Service

  • 7.1 Overview
  • 7.2 Global Pre-Clinical CROs Market, By Service 2018 & 2027 (%)
  • 7.3 Bio-Analysis and DMPK Studies Market
    • 7.3.1 Overview
    • 7.3.2 Global Bio-Analysis and DMPK Studies Market Revenue and Forecasts to 2027 (US$ Mn)
    • 7.3.3 Toxicology Market
      • 7.3.3.1 Overview
      • 7.3.3.2 Global Toxicology Market Revenue and Forecasts to 2027 (US$ Mn)
    • 7.3.4 Other Services Market
      • 7.3.4.1 Overview
      • 7.3.4.2 Global Other Services Market Revenue and Forecasts to 2027 (US$ Mn)

8. Global Pre-Clinical CROs Market Analysis - by End User

  • 8.1 Overview
  • 8.2 Global Pre-Clinical CROs Market, By End User 2018 & 2027 (%)
  • 8.3 Biopharmaceutical Companies Market
    • 8.3.1 Overview
    • 8.3.2 Biopharmaceutical Companies Market Revenue and Forecasts to 2027 (US$ Mn)
  • 8.4 Government & Academic Institutes Market
    • 8.4.1 Overview
    • 8.4.2 Global Government & Academic Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
  • 8.5 Medical Device Companies Market
    • 8.5.1 Overview
    • 8.5.2 Global Medical Device Companies Market Revenue and Forecasts to 2027 (US$ Mn)

9. Pre-Clinical CROs Market Revenue and Forecasts to 2027 - Geographical Analysis

  • 9.1 North America Pre-Clinical CROs Market
    • 9.1.1 Overview
    • 9.1.2 North America Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.1.3 North America Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
    • 9.1.4 North America Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 9.1.5 North America Pre-Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)
    • 9.1.6 US Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.6.1 US Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.6.2 US Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
      • 9.1.6.3 US Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 9.1.7 Canada Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.7.1 Canada Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.7.2 Canada Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
      • 9.1.7.3 Canada Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 9.1.8 Mexico Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.8.1 Mexico Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.8.2 Mexico Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
      • 9.1.8.3 Mexico Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • 9.2 Europe Pre-Clinical CROs Market
    • 9.2.1 Overview
    • 9.2.2 Europe Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.2.3 Europe Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
    • 9.2.4 Europe Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 9.2.5 Europe Pre-Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)
    • 9.2.6 UK Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.2.6.1 UK Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.2.6.2 UK Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
      • 9.2.6.3 UK Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 9.2.7 Germany Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.2.7.1 Germany Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.2.7.2 Germany Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
      • 9.2.7.3 Germany Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 9.2.8 France Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.2.8.1 France Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.2.8.2 France Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
      • 9.2.8.3 France Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 9.2.9 Italy Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.2.9.1 Italy Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.2.9.2 Italy Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
      • 9.2.9.3 Italy Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 9.2.10 Spain Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.2.10.1 Spain Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.2.10.2 Spain Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
      • 9.2.10.3 Spain Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • 9.3 Asia Pacific Pre-Clinical CROs Market
    • 9.3.1 Overview
    • 9.3.2 Asia Pacific Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.3.3 Asia Pacific Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
    • 9.3.4 Asia Pacific Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 9.3.5 Asia Pacific Pre-Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)
    • 9.3.6 China Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.3.6.1 China Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.3.6.2 China Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
      • 9.3.6.3 China Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 9.3.7 India Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.3.7.1 India Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.3.7.2 India Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
      • 9.3.7.3 India Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 9.3.8 Japan Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.3.8.1 Japan Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.3.8.2 Japan Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
      • 9.3.8.3 Japan Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 9.3.9 Australia Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.3.9.1 Australia Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.3.9.2 Australia Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
      • 9.3.9.3 Australia Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 9.3.10 South Korea Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.3.10.1 South Korea Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.3.10.2 South Korea Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
      • 9.3.10.3 South Korea Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • 9.4 Middle East & Africa Pre-Clinical CROs Market
    • 9.4.1 Overview
    • 9.4.2 Middle East & Africa Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.4.3 Middle East & Africa Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
    • 9.4.4 Middle East & Africa Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 9.4.5 Middle East & Africa Pre-Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)
    • 9.4.6 South Africa Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.4.6.1 South Africa Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.4.6.2 South Africa Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
      • 9.4.6.3 South Africa Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 9.4.7 Saudi Arabia Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.4.7.1 Saudi Arabia Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.4.7.2 Saudi Arabia Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
      • 9.4.7.3 Saudi Arabia Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 9.4.8 UAE Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.4.8.1 UAE Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.4.8.2 UAE Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
      • 9.4.8.3 UAE Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • 9.5 South And Central America Pre-Clinical CROs Market
    • 9.5.1 Overview
    • 9.5.2 South and Central America Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.5.3 South and Central America Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
    • 9.5.4 South and Central America Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 9.5.5 South and Central America Pre-Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)
    • 9.5.6 Argentina Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.5.6.1 Argentina Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.5.6.2 Argentina Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
      • 9.5.6.3 Argentina Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 9.5.7 Brazil Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.5.7.1 Brazil Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.5.7.2 Brazil Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
      • 9.5.7.3 Brazil Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10. Pre-Clinical CROs Market - Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in the Pre-Clinical CROs Market, 2016-2019
  • 10.3 Organic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Organic Growth Strategies in the Pre-Clinical CROs Market, 2016-2019 (%)
    • 10.4.1 Expansion & Other Activities
      • 10.4.1.1 Recent Expansion & Other Activities By Players In The Pre-Clinical CROs Market
    • 10.4.2 Product Launches
      • 10.4.2.1 Recent Product Launches By Players In The Pre-Clinical CROs Market
  • 10.5 Inorganic Growth Strategies
    • 10.5.1 Overview
  • 10.6 Inorganic Growth Strategies in the Pre-Clinical CROs Market, 2016-2019 (%)
    • 10.6.1 Acquisitions
      • 10.6.1.1 Recent Acquisitions By Players In The Pre-Clinical CROs Market
    • 10.6.2 Agreements & Collaborations
      • 10.6.2.1 Recent Agreements & Collaborations By Players In The Pre-Clinical CROs Market
    • 10.6.3 Partnerships
      • 10.6.3.1 Recent Partnerships By Players In The Pre-clinical CROs Market

11. Pre-Clinical CROs Market-Key Company Profiles

  • 11.1 MD Biosciences, Inc.
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Financial Overview
    • 11.1.4 Services Portfolio
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 WuXi AppTec
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Financial Overview
    • 11.2.4 Service Portfolio
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Pharmaceutical Product Development, LLC.
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Financial Overview
    • 11.3.4 Service Portfolio
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Covance Inc.
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Financial Information
    • 11.4.4 Service Portfolio
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Charles River
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Financial Overview
    • 11.5.4 Services Portfolio
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 PRA Health Sciences, Inc.
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Financial Overview
    • 11.6.4 Service Portfolio
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Medpace
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Financial Overview
    • 11.7.4 Service Portfolio
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Parexel International Corporation
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Financial Information
    • 11.8.4 Service Portfolio
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 ICON Plc
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Financial Overview
    • 11.9.4 Service Portfolio
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 Eurofins Scientific
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Financial Overview
    • 11.10.4 Product Portfolio
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary of Terms